New advances in injectable therapies for the treatment of incontinence and vesicoureteral reflux

R. T. Kershen, A. Atala

Research output: Contribution to journalArticle

102 Scopus citations

Abstract

Clinical experience over the last two decades has demonstrated that the endoscopic correction of primary vesicoureteral reflux and urinary incontinence caused by intrinsic sphincteric dysfunction is both possible and effective. The ideal material for use in these regards has yet to be developed. As a result, there has been a continuing research effort directed towards the development of new injectable substances. Nonautologous substances, such as Teflon, collagen, and Deflux, and autologous substances such as fat, chondrocytes and muscle, have been used either clinically or are under investigation. Although the ideal substance has yet to be determined, many of the substances currently under development appear promising. The use of a particular substance may best be determined by the clinical circumstance involving each individual patient.

Original languageEnglish (US)
Pages (from-to)81-94
Number of pages14
JournalUrologic Clinics of North America
Volume26
Issue number1
DOIs
StatePublished - Jan 1 1999

    Fingerprint

ASJC Scopus subject areas

  • Urology

Cite this